BRD7552

Cat. No.: OB0225WX-2683

Appearance: Solid

Purity: ≥97%

Identity: Confirmed by NMR, and HPLC.

Size:

INQUIRY Datasheet MSDS

Add to basket

Product Overview

Description: BRD7552 functions as a chemical inducer of the transcription factor PDX1, leading to an up-regulation of insulin expression at the molecular level.

Synonym: 1137359-47-7; BRD-7552; Alpha-D-Glucopyranoside, methyl, 2,3-bis(N-1,3-benzodioxol-5-ylcarbamate) 4-[N-[4-(ethoxycarbonyl)phenyl]carbamate]; Ethyl 4-[[(2R,3R,4S,5R,6S)-4,5-bis(1,3-benzodioxol-5-ylcarbamoyloxy)-2-(hydroxymethyl)-6-methoxyoxan-3-yl]oxycarbonylamino]benzoate; Methyl [2,3-O-bis(Benzo[1,3]dioxol-5-yl-carbamoyl)]-4-O-(4-ethoxycarbonyl-phenylcarbamoyl)-alpha-D-glucopyranoside; ethyl 4-[({[(2R,3R,4S,5R,6S)-4,5-bis({[(2H-1,3-benzodioxol-5-yl)carbamoyl]oxy})-2-(hydroxymethyl)-6-methoxyoxan-3-yl]oxy}carbonyl)amino]benzoate; Ethyl 4-(((((2R,3R,4S,5R,6S)-4,5-bis((benzo[d][1,3]dioxol-5-ylcarbamoyl)oxy)-2-(hydroxymethyl)-6-methoxytetrahydro-2H-pyran-3-yl)oxy)carbonyl)amino)benzoate

CAS No.: 1137359-47-7

Compound CID: 23891512

Formula: C₃₃H₃₃N₃O₁₅

Formula Weight: 711.63

Specification

Stability: 3 years in powder form.

Storage: Storage at -20°C.

Applications: BRD7552 is employed in metabolic and stem cell research as a small molecule inducer to investigate the promotion of pancreatic beta-cell differentiation and the enhancement of insulin production.